Skip to main content
. 2022 May 29;45(8):zsac123. doi: 10.1093/sleep/zsac123

Table 1.

Demographic and clinical characteristics

Acute TBI
[1]
(n =11)
Acute OSCI
[2]
(n = 14)
Chronic TBI
[3]
(n = 43)
Healthy controls
[4]
(n = 36)
One-way ANOVA/chi-square Tukey's post-hoc
Age, years 28.9 (13.4) 39.9 (17.1) 31.9 (13.5) 30.5 (12.7) p = 0.138
Sex, m:f 6:5 11:3 29:14 25:11 p = 0.642
GCS at hospital admission 6.3 (3.0) 8.4 (3.3) p = 0.062
Duration of post-traumatic amnesia, days 14.1 (18.0) 14.8 (15.4) p = 0.896
ICU length of stay, days 13.9 (11.1) 3.5 (4.7) 11.3 (9.9) p = 0.002 2 < 1,3
Hospital length of stay, days 31.7 (20.1) 28.4 (11.6) 30.7 (17.6) p = 0.866
Time since injury at moment of testing, days 22.0 (14.8) 17.4 (7.3) 730.6 (308.5) p < 0.0001 1,2 < 3
Medication intake
 Opioids, n (%) 4 (36.4) 12 (85.7) 0 (0.0) 0 (0.0)
 Acetaminophen, n (%) 6 (54.5) 13 (92.9) 1 (2.3) NA
 Other analgesics and muscle relaxants, n (%) 0 (0.0) 7 (50.0) 0 (0.0) NA
 Anti-inflammatories, n (%) 0 (0.0) 2 (14.3) 3 (7.0) NA
 Psychostimulants, n (%) 4 (36.4) 0 (0.0) 2 (4.7) 0 (0.0)
 Antidepressants, n (%) 1 (9.1) 0 (0.0) 6 (14.0) 0 (0.0)
 Anxiolytics, n (%) 1 (9.1) 3 (21.4) 0 (0.0) 0 (0.0)
 Anticonvulsants, n (%) 3 (27.3) 0 (0.0) 2 (4.7) 0 (0.0)
 Antipsychotics, n (%) 3 (27.3) 1 (7.1) 1 (2.3) 0 (0.0)

Medication intake for all groups is defined as any intake at any point during testing or the day prior. Data are presented as mean (SD) unless specified otherwise. NA, not available.

Bold indicates statistically significant values.